Calvin Sandra: insider trades.
Calvin Sandra reported 6 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($335K), across 1 company.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- Calvin Sandra
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | Officer · SVP, CHIEF ACCOUNTING OFFICER | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-15 | Travere Therapeutics, Inc. | M | 2,500 | $27.5 | 44,853 | Form 4 |
| 2026-09-15 | Travere Therapeutics, Inc. | M | 1,250 | $22.4 | 46,103 | Form 4 |
| 2026-09-15 | Travere Therapeutics, Inc. | S | 300 | $63.66 | 42,353 | Form 4 |
| 2026-09-15 | Travere Therapeutics, Inc. | S | 4,275 | $62.14 | 43,453 | Form 4 |
| 2026-09-15 | Travere Therapeutics, Inc. | S | 800 | $62.85 | 42,653 | Form 4 |
| 2026-09-15 | Travere Therapeutics, Inc. | M | 1,625 | $20.46 | 47,728 | Form 4 |
Questions
What stock did Calvin Sandra buy or sell?
Calvin Sandra reported 6 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($335K), across 1 company.
Is Calvin Sandra the same person as other filers with this name?
This page covers SEC CIK 1882909 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/calvin-sandra-1882909.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.